Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Happinose
- Development stage
- Unknown
- Lead developer
- Alcon
- Modality
- Small Molecules
- Administration
- Topical, Intranasal
01
Overview
Happinose is an over-the-counter (OTC) soothing nasal decongestant balm developed and marketed by Diomed Developments Ltd. The product contains levomenthol (0.3% w/w) as its active ingredient, formulated in a translucent, lubricating ointment base for topical application to the nasal passages. Its mechanism of action involves the stimulation of cold-sensitive sensory receptors in the nasal mucosa, which produces a cooling sensation that helps relieve symptoms of congestion associated with the common cold, catarrh, head colds, and hay fever. It is classified as a General Sales List (GSL) medicine in the United Kingdom.
- Brand names
- Happinose
- Other names
- Happinose Nasal Balm
02
Targets
TRPM8 (Transient receptor potential cation channel subfamily M member 8)
Beyond the preview
Go deeper on Happinose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Happinose.